Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Scatton

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Journal of Neural Transmission|January 1, 1988
Lack of correlation between DST results and urinary MHPG in depressed inpatientsH Lôo, M F Poirier, T Dennis, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemiaB Gotti, D Duverger, J Bertin, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.
Advances in Neurology|January 1, 1987
Progressive supranuclear palsy: anatomoclinical and biochemical considerationsY Agid, F Javoy-Agid, M Ruberg, et al.
Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.
Advances in Biochemical Psychopharmacology|January 1, 1985
Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative resultsH Loo, C Benkelfat, B Scatton, et al.
Arzneimittel-Forschung|May 1, 1995
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodentJ Benavides, H Schoemaker, C Dana, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityH Schoemaker, Y Claustre, D Fage, et al.
Annals of Neurology|November 1, 1985
Dopaminergic and cholinergic lesions in progressive supranuclear palsyM Ruberg, F Javoy-Agid, E Hirsch, et al.
L'Encephale|January 1, 1983
[Study of noradrenaline metabolism in depressed patients by the determination of plasma dihydroxyphenylethylene glycol]H Lôo, B Scatton, T Dennis, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Journal of Neural Transmission|January 1, 1988
Lack of correlation between DST results and urinary MHPG in depressed inpatientsH Lôo, M F Poirier, T Dennis, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1988
Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemiaB Gotti, D Duverger, J Bertin, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1985
Non-benzodiazepine anxiolytics: potential activity of phenylpiperazines without 3H-diazepam displacing actionK G Lloyd, H Depoortere, B Scatton, et al.
Advances in Neurology|January 1, 1987
Progressive supranuclear palsy: anatomoclinical and biochemical considerationsY Agid, F Javoy-Agid, M Ruberg, et al.
Biological Psychiatry|August 1, 1986
Lack of correlation between plasma DOPEG and urinary MOPEG levels in depressed patientsH Lôo, T Dennis, J M Vanelle, et al.
Advances in Biochemical Psychopharmacology|January 1, 1985
Hypothesis of a deficiency of central noradrenergic input in DST nonsuppressor depressed patients. A clinical study with determination of DST and plasma DOPEG: negative resultsH Loo, C Benkelfat, B Scatton, et al.
Arzneimittel-Forschung|May 1, 1995
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodentJ Benavides, H Schoemaker, C Dana, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityH Schoemaker, Y Claustre, D Fage, et al.
Annals of Neurology|November 1, 1985
Dopaminergic and cholinergic lesions in progressive supranuclear palsyM Ruberg, F Javoy-Agid, E Hirsch, et al.
L'Encephale|January 1, 1983
[Study of noradrenaline metabolism in depressed patients by the determination of plasma dihydroxyphenylethylene glycol]H Lôo, B Scatton, T Dennis, et al.
Pageof 26